Pharmacovigilance und Vigilance Service

Pharmacovigilance, the monitoring of drug safety, is mandatory for sponsors of clinical trials and for marketing authorisation holders or applicants for a marketing authorisation. This is not only about the legally compliant handling of reports received about adverse drug reactions, but in particular about the assessment of the risk-benefit profile of an active substance or a medicinal product.
There are also mandatory vigilance tasks for medical devices.

SocraMetrics offers the one-stop shop around pharmacovigilance/vigilance for pharmaceutical companies. Our team, with its many years of inspection-proven experience, sets up and maintains pharmacovigilance systems and coordinates our clients' global project management. In doing so, SocraMetrics can either cover the entire obligations of the pharmaceutical company or only partial aspects - depending on the company structure.

We support companies from the very first step when it comes to planning a clinical trial, and our services cover all aspects of pharmacovigilance and thus the entire life cycle of the product: from the trial to the marketing authorisation and the regular marketing process.

Our highly qualified team also acts as the person responsible for pharmacovigilance for the pharmaceutical company (EU-QPPV, UK-QPPV, Graduated Plan Officer in Germany).

Services for sponsors of clinical trials:

Global pharmacovigilance services
Provision of the Drug Safety Officers
Generation and maintenance
- Protocols
- Investigator’s information
- Development safety update reports, DSURs
- Safety Management Plans
Processing and reporting of safety-relevant reports
Literature search
Preparation and maintenance of the clinical quality systems
GCP-Trainings

Services for applicants of & marketing authorisation holders

Global project and contract management
EU-QPPV, UK-QPPV, Graduated Plan Officer, Safety Officer for Medical Devices
Preparation and maintenance of Pharmacovigilance System Master File (PSMF)
Preparation and maintenance of Risk Management Plans (RMPs)
Preparation and maintenance of Periodic Safety Update Reports (PSURs) and Periodic Benefit-Risk Evaluation Reports (PBRERs)
Post Authorisation Safety Studies (PASS) and Post Authorisation Efficacy Studies (PAES)
Signal detection
Handling of Adverse Drug Reactions and other safety-relevant information
Management of pharmaceutical-technical risks of medicinal products and medical devices
Literature search
Preparation and maintenance of the Pharmacovigilance Quality System
GVP training
Management of pharmakovigilance audits and inspektions
Medical assessments

For more information you can download our info-flyer as pdf file.

Download Pharmacovigilance Flyer (1.19 Mb) PDF